Komodo Health & Partners Present 33 Real-World Evidence Research Studies at ISPOR 2024 [Yahoo! Finance]
NeoGenomics, Inc. (NEO)
Last neogenomics, inc. earnings: 4/28 07:00 am
Check Earnings Report
US:NASDAQ Investor Relations:
ir.neogenomics.com
Company Research
Source: Yahoo! Finance
Komodo Insights Power Three Studies Named Finalists for ISPOR 2024 Research Presentation Awards SAN FRANCISCO & ATLANTA, May 06, 2024 BUSINESS WIRE )--Komodo Health today announced the publication of 33 new health economics and outcomes research (HEOR) studies using its Healthcare Map and AI-powered technology platform. The studies, to be featured at the 2024 International Society for Pharmacoeconomics and Outcomes Research (ISPOR) Global Conference, shed light on important disease trends spanning women's health, oncology, mental health, hypertension, neurology, and more. Researchers from top institutions and Life Sciences companies leveraged Komodo's technology platform and Healthcare Map to reveal insights focused on patterns in clinical outcomes, healthcare resource utilization (HCRU), disease burden, comparative effectiveness, and potential complications associated with approved treatments for specific patient populations. For example, Takeda Pharmaceuticals used Komodo's H
Show less
Read more
Impact Snapshot
Event Time:
NEO
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
NEO alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
NEO alerts
High impacting NeoGenomics, Inc. news events
Weekly update
A roundup of the hottest topics
NEO
News
- Kathryn McKenzie is Superfeet's New CFO — And the Third Woman in Shoes Named to the Top Finance Role This Week [Yahoo! Finance]Yahoo! Finance
- NeoGenomics, Inc. (NASDAQ:NEO) Q1 2024 Earnings Call Transcript [Yahoo! Finance]Yahoo! Finance
- NeoGenomics, Inc. (NASDAQ: NEO) had its price target lowered by analysts at BTIG Research from $23.00 to $21.00. They now have a "buy" rating on the stock.MarketBeat
- NeoGenomics First Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags [Yahoo! Finance]Yahoo! Finance
- NeoGenomics, Inc. (NASDAQ: NEO) had its price target lowered by analysts at TD Cowen from $21.00 to $20.00. They now have a "buy" rating on the stock.MarketBeat
NEO
Earnings
- 4/30/24 - Beat
NEO
Sec Filings
- 5/17/24 - Form 4
- 5/15/24 - Form 144
- 5/14/24 - Form 4
- NEO's page on the SEC website